HIV/AIDS

  • A therapeutic HIV vaccine clinical trial induces viral control in 5 people without taking antiretroviral therapy
    • Notas de prensa

    A therapeutic HIV vaccine clinical trial induces viral control in 5 people without taking antiretroviral therapy

    A clinical trial conducted by the IrsiCaixa AIDS Research Institute, supported by the Obra Social "la Caixa" and the Department of Health of the Generalitat de Catalunya, and the Fight AIDS Foundation has induced HIV control in 5 people who have been...

    Read more
  • Therapeutic AIDS vaccine designed by the HIVACAT reduces the viral load in the majority of AIDS patients
    • Notas de prensa

    Therapeutic AIDS vaccine designed by the HIVACAT reduces the viral load in the majority of AIDS patients

    Although the decrease is not sufficient, the first therapeutic vaccine, designed from the dendritic cells of the actual patient by the Hospital Clinic of Barcelona-IDIBAPS has achieved a significant response in the majority of patients. The objective...

    Read more
  • ”la Caixa” Social and Cultural Outreach Projects inaugurates the CaixaForum Madrid, a new concept in social and cultural centres
    • Notas de prensa

    ”la Caixa” Social and Cultural Outreach Projects inaugurates the CaixaForum Madrid, a new concept in social and cultural centres

    The CaixaForum Madrid is the result of a single desire: to extend and diversity the social and cultural activities offered by "la Caixa" Social and Cultural Outreach Projects in the capital to benefit of its citizens. It represents a new concept in s...

    Read more
  • The irsiCaixa Foundation organises the 4th International Symposium on HIV Eradication at the Hospital Universitari Germans Trias i Pujol
    • Notas de prensa

    The irsiCaixa Foundation organises the 4th International Symposium on HIV Eradication at the Hospital Universitari Germans Trias i Pujol

    On 14 November the irsiCaixa Foundation will host the 4th International Symposium on HIV Eradication which will present, among other recent findings, the first results concerning the therapeutic vaccine for patients already infected by the human immu...

    Read more